KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to $6.6 billion.

  • Eli Lilly's Consolidated Net Income rose 5052.16% to $6.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 9490.08%. This contributed to the annual value of $20.6 billion for FY2025, which is 9490.08% up from last year.
  • Per Eli Lilly's latest filing, its Consolidated Net Income stood at $6.6 billion for Q4 2025, which was up 5052.16% from $5.6 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Consolidated Net Income registered a high of $6.6 billion during Q4 2025, and its lowest value of -$57.4 million during Q3 2023.
  • Moreover, its 5-year median value for Consolidated Net Income was $1.8 billion (2022), whereas its average is $2.4 billion.
  • Per our database at Business Quant, Eli Lilly's Consolidated Net Income plummeted by 10395.4% in 2023 and then surged by 179041.81% in 2024.
  • Quarter analysis of 5 years shows Eli Lilly's Consolidated Net Income stood at $1.7 billion in 2021, then rose by 12.26% to $1.9 billion in 2022, then rose by 12.98% to $2.2 billion in 2023, then soared by 101.43% to $4.4 billion in 2024, then skyrocketed by 50.52% to $6.6 billion in 2025.
  • Its last three reported values are $6.6 billion in Q4 2025, $5.6 billion for Q3 2025, and $5.7 billion during Q2 2025.